ATR
AptarGroup Inc
NYSE: ATR · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$119.96
+0.72% today
Updated 2026-06-05
Market cap
$7.51B
P/E ratio
20.16
P/S ratio
1.94x
EPS (TTM)
$5.84
Dividend yield
1.60%
52W range
$102 – $162
Volume
0.5M
WallStSmart proprietary scores
53
out of 100
Grade: C
Hold
Investment rating
4.0
Growth
C6.0
Quality
B6.0
Profitability
B4.0
Valuation
C3/9
Piotroski F-Score
Weak
2.6
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →199 stocks currently score above 75
Price targets
Analyst target
$160.43
+33.74%
12-Month target
$123.84
+3.23%
Intrinsic (DCF)
$97.16
Margin of safety
-44.10%
2 Strong Buy4 Buy2 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $53.30M — positive
+ Revenue growth 10.80% QoQ
Risks
- Piotroski 3/9 — weak financial health
- 44.10% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $3.32B | $3.49B | $3.58B | $3.78B | $3.87B |
| Net income | $239.29M | $284.49M | $374.54M | $392.79M | $72.67M |
| EPS | — | — | — | — | $5.84 |
| Free cash flow | $163.00M | $256.84M | $349.22M | $299.58M | $53.30M |
| Profit margin | 7.20% | 8.16% | 10.45% | 10.40% | 9.98% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-15 | GANDHI, ADITYA | Buy | 2,664 | — |
| 2026-06-09 | PRIEUR, MARC | Sale | 4,553 | $115.53 |
| 2026-06-09 | PRIEUR, MARC | Sale | 447 | $116.08 |
Peer comparison
Smart narrative
AptarGroup Inc trades at $119.96. representing a P/E of 20.16x trailing earnings. Our Smart Value Score of 53/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 2.57, it sits in the grey zone. TTM revenue stands at $3.87B. with profit margins at 9.98%. Our DCF model estimates intrinsic value at $97.16.
Frequently asked questions
What is AptarGroup Inc's stock price?
AptarGroup Inc (ATR) trades at $119.96, on a P/E of 20.2x and a P/S of 1.9x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is AptarGroup Inc overvalued?
AptarGroup Inc carries a Smart Value Score of 53/100 (Grade C), which we rate Hold. That score blends growth, quality, and valuation into one read. On valuation specifically, our conservative DCF puts intrinsic value at $97.16 against the $119.96 price, so on cash flow terms the market is paying a premium for AptarGroup Inc's growth. The Hold rating reflects that growth and quality, while the DCF flags that the price already assumes a lot.
What is the price target of AptarGroup Inc (ATR)?
The 12-month analyst consensus target is $160.43, about 33.7% above the current $119.96. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of AptarGroup Inc (ATR)?
Our DCF model estimates intrinsic value at $97.16, a -44.1% margin of safety versus today's $119.96. Intrinsic value is what the projected cash flows are worth today. A negative reading means the price is running ahead of that conservative estimate, leaving little downside cushion if growth slows.
What is AptarGroup Inc's revenue?
AptarGroup Inc's trailing twelve-month revenue is $3.87B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
AptarGroup Inc's Altman Z-Score is 2.57, which places it in the grey zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio1.94x
ROE14.70%
Beta0.40
50D MA$121.02
200D MA$126.41
Shares out0.06B
Float0.06B
Short ratio—
Avg volume0.5M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—